Literature DB >> 8876700

Neoplastic transformation of mouse C3H10T1/2 cells following exposure to neutrons does not involve mutation of ras gene as analyzed by SSCP and cycle sequencing.

G A Freyer1, D A Palmer, Y Yu, R C Miller, T K Pandita.   

Abstract

About 25% of human tumors contain a mutated member of the ras gene family. Neutron exposure is an occupational risk in several work places and while we know that cells exposed to neutrons can become transformed, the molecular basis of this process is not understood. To determine whether neutron-induced cellular transformation involves ras mutation, C3H10T1/2 cells were exposed to a single dose of 5.9 MeV neutrons. Type II and type III foci were isolated and established as cell lines. A total of 34 foci were selected and expanded for analysis of tumorigenicity, chromosomal aberrations and mutations in members of the ras gene family. The presence of mutations in genomic DNA in N-ras or K-ras of each focus was examined by either single-strand conformational polymorphism (SSCP) analysis or by asymmetric PCR coupled cell cycle sequence analysis. Although chromosomal aberrations were detected at metaphase, no alterations in either ras gene were detected. We conclude that in vitro neutron-induced transformation must occur through a mechanism other than ras mutation.

Entities:  

Mesh:

Year:  1996        PMID: 8876700     DOI: 10.1016/0027-5107(96)00130-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Mice and the A-Bomb: Irradiation Systems for Realistic Exposure Scenarios.

Authors:  Guy Garty; Yanping Xu; Carl Elliston; Stephen A Marino; Gerhard Randers-Pehrson; David J Brenner
Journal:  Radiat Res       Date:  2017-02-17       Impact factor: 2.841

2.  Altered telomere nuclear matrix interactions and nucleosomal periodicity in ataxia telangiectasia cells before and after ionizing radiation treatment.

Authors:  L B Smilenov; S Dhar; T K Pandita
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

3.  Novel neutron sources at the Radiological Research Accelerator Facility.

Authors:  Yanping Xu; Guy Garty; Stephen A Marino; Thomas N Massey; Gerhard Randers-Pehrson; Gary W Johnson; David J Brenner
Journal:  J Instrum       Date:  2012-03-16       Impact factor: 1.415

4.  Stress Responses as Master Keys to Epigenomic Changes in Transcriptome and Metabolome for Cancer Etiology and Therapeutics.

Authors:  Atanu Mondal; Apoorva Bhattacharya; Vipin Singh; Shruti Pandita; Albino Bacolla; Raj K Pandita; John A Tainer; Kenneth S Ramos; Tej K Pandita; Chandrima Das
Journal:  Mol Cell Biol       Date:  2021-11-08       Impact factor: 5.069

5.  The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis.

Authors:  Arun Gupta; T Geraldine Guerin-Peyrou; Girdhar G Sharma; Changwon Park; Manjula Agarwal; Ramesh K Ganju; Shruti Pandita; Kyunghee Choi; Saraswati Sukumar; Raj K Pandita; Thomas Ludwig; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

6.  Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice.

Authors:  Clayton R Hunt; David J Dix; Girdhar G Sharma; Raj K Pandita; Arun Gupta; Margo Funk; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  Human heterochromatin protein 1 isoforms HP1(Hsalpha) and HP1(Hsbeta) interfere with hTERT-telomere interactions and correlate with changes in cell growth and response to ionizing radiation.

Authors:  Girdhar G Sharma; Kyu-kye Hwang; Raj K Pandita; Arun Gupta; Sonu Dhar; Julie Parenteau; Manjula Agarwal; Howard J Worman; Raymund J Wellinger; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  β2-spectrin depletion impairs DNA damage repair.

Authors:  Nobuo Horikoshi; Raj K Pandita; Kalpana Mujoo; Shashank Hambarde; Dharmendra Sharma; Abid R Mattoo; Sharmistha Chakraborty; Vijaya Charaka; Clayton R Hunt; Tej K Pandita
Journal:  Oncotarget       Date:  2016-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.